Eruptive Pseudoangiomatosis: Report of an Adult Case and Unifying Hypothesis of the Pathogenesis of Paediatric and Adult CasesChaniotakis I.a · Nomikos K.a · Gamvroulia C.a · Zioga A.b · Stergiopoulou C.a · Bassukas I.D.a
Departments of aSkin and Venereal Diseases and bPathology, University of Ioannina Medical School, Ioannina, Greece
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
One month after the onset of immunosuppressive treatment with corticosteroids and mycophenolate mofetil for a newly diagnosed pemphigus vulgaris, a 50-year-old female patient developed a new eruption clinically and histomorphologically consistent with eruptive pseudoangiomatosis (EP). Its self-limited course further confirmed this diagnosis. Although initially described as a paediatric eruption, meanwhile more adult cases of EP (30 out of a total of 53 cases identified by a Medline search) are reported in the literature. The review of adult cases of EP disclosed some common clinical and epidemiological characteristics: adult EP cases tend to cluster in the Mediterranean region of Europe, develop during the summer months, sometimes in the form of limited micro-epidemics, affect immunocompromised individuals and have lesions confined to the exposed skin sites. These characteristics, together with the exanthematic nature of the disease in children, point to some vector-transmitted infectious agent as the cause of this probably underdiagnosed disease.
© 2007 S. Karger AG, Basel
- Cherry JD, Bobinski JE, Horvath FL, et al: Acute hemangioma-like lesions associated with echo viral infections. Pediatrics 1969;44:498–502.
- Prose NS, Tope W, Miller SE, et al: Eruptive pseudoangiomatosis: a unique childhood exanthem? J Am Acad Dermatol 1993;29:857–859.
- Navarro V, Molina I, Montesinos E, et al: Eruptive pseudoangiomatosis in an adult. Int J Dermatol 2000;39:237–238.
- Guillot B, Dandurand M: Eruptive pseudoangiomatosis arising in adulthood: 9 cases. Eur J Dermatol 2000;10:455–458.
- Restano L, Cavalli R, Colonna C, et al: Eruptive pseudoangiomatosis caused by an insect bite. J Am Acad Dermatol 2005;52:174–175.
Guillot B, Chraibi H, Girard C, et al: Pseudoangiomatose éruptive du nourrisson et du nouveau-né. Ann Dermatol Vénéréol 2005;132:966–969.
- Neri I, Patrizi A, Guerrini V, et al: A new case of eruptive pseudoangiomatosis: ultrastructural study. J Eur Acad Dermatol Venereol 2004;18:387–389.
- Stoebner PE, Templier I, Ligeron C, et al: Familial eruptive pseudoangiomatosis. Dermatology 2002;205:306–307.
- Angelo C, Provini A, Ferranti G, et al: Eruptive pseudoangiomatosis. Pediatr Dermatol 2002;19:243–245.
- Larralde M, Ballona R, Correa N, et al: Eruptive pseudoangiomatosis. Pediatr Dermatol 2002;19:76–77.
- Neri I, Patrizi A, Guerrini V, et al: Eruptive pseudoangiomatosis. Br J Dermatol 2000;143:435–438.
- Gonzalez Ensenat MA, Vicente Villa MA, Castella Badrinas NC, et al: Pseudoangiomatosis eruptiva: a propósito de un caso. An Esp Pediatr 1997;46:69–70.
Mazereeuw-Hautier J, Cambon L, Bonafe JL: Pseudoangiomatose éruptive chez un adulte transplanté rénal. Ann Dermatol Vénéréol 2001;128:55–56.
- Jung J, Kim SC: Eruptive pseudoangiomatosis: three cases in Korean middle-aged women. Acta Derm Venereol 2004;84:241–242.
- Venturi C, Zendri E, Medici MC, et al: Eruptive pseudoangiomatosis in adults: a community outbreak. Arch Dermatol 2004;140:757–758.
Davaine AC, Viseux V, Staroz F, et al: Pseudo-angiomatose éruptive associée à une séroconversion pour les entérovirus. Ann Dermatol Vénéréol 2004;131:987–988.
- Lipsker D, Saurat J-H: A new concept: paraviral eruptions. Dermatology 2005;211:309–311.
- Ban M, Ichiki Y, Kitajima Y: An outbreak of eruptive pseudoangiomatosis-like lesions due to mosquito bites: erythema punctatum Higuchi. Dermatology 2004;208:356–359.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.